Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

Northwest Biotherapeutics, Inc. (NWBO)

-NasdaqCM
6.41 0.13(2.07%) Jul 25, 4:00PM EDT
Prev Close:6.28
Open:6.23
Bid:5.90 x 600
Ask:N/A
1y Target Est:5.00
Beta:2.98
Next Earnings Date:N/A
Day's Range:6.19 - 6.45
52wk Range:3.10 - 10.64
Volume:384,034
Avg Vol (3m):1,229,860
Market Cap:366.62M
P/E (ttm):N/A
EPS (ttm):-2.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NWBO

Comparison

Symbol% ChgMkt Cap
NWBOUp 2.07%366.62M
AGEN201.64M
DNDN331.94M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):534.50
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.85
Quarterly EPS Est (Jun-14) :-0.36
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Northwest Biotherapeutics, Inc., a development stage biotechnology company, discovers and develops immunotherapy products to treat cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback